Cymbalta vs Effexor: Comparing the 2 Main SNRIs

Maybe your back has ached for a year, right alongside the low mood. Maybe anxiety has your shoulders up by your ears and your heart pounding at night. Your prescriber mentions an SNRI, and two names come up more than any others: Cymbalta and Effexor. They sound interchangeable, but they differ in the places that matter most to your daily life.

Both drugs work on two chemical messengers in your brain and spinal cord, serotonin and norepinephrine, by slowing how quickly nerve cells reabsorb them. That’s why they’re called serotonin and norepinephrine reuptake inhibitors, or SNRIs. Norepinephrine also helps regulate pain signals and blood pressure, and the Cymbalta prescribing information links duloxetine’s pain-relieving action to that same dual effect in the central nervous system. Choosing between the two takes precision about pain, blood pressure, and how you’d eventually stop.

For many people, Effexor was the first SNRI they met. Effexor XR was approved in 1997, and the Effexor XR prescribing information lists placebo-controlled trial evidence for major depression, generalized anxiety disorder, social anxiety disorder, and panic disorder. In longer studies, people who stayed on it had lower relapse rates than those switched to placebo. The results are real, and the science is well established.

But Effexor isn’t the only well-studied SNRI anymore, and at Siggy we think the choice should start with your whole body rather than the name that comes to mind first.

Cymbalta (duloxetine) is an SNRI whose FDA approvals extend beyond depression and generalized anxiety into diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain. This guide compares the two on the three differences that most often decide the choice: pain, blood pressure, and withdrawal. Neither drug is better for everyone, and the right match for you comes down to the evidence.

What This Page Covers

• How Are Cymbalta and Effexor Alike?
• Cymbalta vs Effexor at a Glance
• Which Is Better for Nerve Pain and Fibromyalgia?
• How Do They Affect Blood Pressure?
• Which Is Harder to Stop?
• How Do You and Your Prescriber Choose?
• How Siggy Fits In
• Start Your Anonymous Intake

How Are Cymbalta and Effexor Alike?

They share a class, a mechanism, and many side effects. Nausea is the most common for both. In each drug’s own placebo-controlled trials, nausea affected 30% of people on Effexor XR versus 12% on placebo, and 23% of people on Cymbalta versus 8% on placebo, according to their labels. Those numbers come from separate trials, so they aren’t a direct comparison.

Both labels carry the standard antidepressant boxed warning about suicidal thoughts in children, teens, and young adults. Both warn about serotonin syndrome when combined with other serotonergic drugs, and both recommend a gradual taper rather than stopping suddenly. For a broader look at how this class compares with SSRIs, see our guide to SNRIs vs SSRIs.

Cymbalta vs Effexor at a Glance

The differences show up in the approved uses, the cardiovascular profile, and the pharmacology that shapes withdrawal. This summary draws on the two FDA labels cited above:

Feature	Cymbalta (Duloxetine)	Effexor XR (Venlafaxine)
Approved pain uses	Diabetic nerve pain, fibromyalgia, musculoskeletal pain	None
Approved mental health uses	Depression, generalized anxiety	Depression, generalized anxiety, social anxiety, panic
Blood pressure in label trials	Small average rise	Dose-related rise, sustained hypertension cases
Half-life	About 12 hours	About 5 hours, 11 for active metabolite
Smallest capsule	20 mg	37.5 mg

For dosing ranges, liver and kidney cautions, and how switching works, our companion guide on Effexor vs Cymbalta goes deeper.

Which Is Better for Nerve Pain and Fibromyalgia?

Cymbalta has the stronger case. In a Cochrane review of duloxetine, 60 mg a day was effective for painful diabetic neuropathy over 12 weeks, with a number needed to treat of 5. That means about 1 in 5 people got at least 50% pain relief who wouldn’t have on placebo. The review found lower-quality evidence that duloxetine also helps fibromyalgia, with a number needed to treat of 8, and 120 mg worked no better than 60 mg. The Cymbalta label’s target dose for both nerve pain and fibromyalgia is 60 mg once daily.

Effexor’s pain evidence is weaker. Using venlafaxine for pain is off-label, and a Cochrane review of venlafaxine for neuropathic pain found little compelling evidence to support it, citing small studies, risk of bias, and strong placebo effects.

There’s a nuance worth knowing. An international pain guideline review from the Neuropathic Pain Special Interest Group pooled duloxetine and venlafaxine together, estimated a number needed to treat of 6.4, and recommended SNRIs as a first-line class for neuropathic pain. Most of the strongest single-drug data in that class belong to duloxetine.

How Do They Affect Blood Pressure?

Both raise blood pressure in some people, but the Effexor label describes a bigger effect. It reports dose-related increases in systolic and diastolic pressure and cases of sustained hypertension. In its depression trials at doses from 75 to 375 mg a day, 3% of people had sustained elevations in diastolic pressure.

Dose matters a lot. A 3,744-patient analysis found venlafaxine’s effect on diastolic pressure was highly dose-dependent and clinically significant only above 300 mg a day. It also found that venlafaxine didn’t worsen blood pressure control in people who already had high readings at baseline.

The Cymbalta label reports average increases of 0.5 mm Hg systolic and 0.8 mm Hg diastolic, compared with small decreases on placebo, and no significant difference in sustained elevations. Cymbalta has a different cardiovascular caution, though: its label warns about orthostatic hypotension, a drop in blood pressure when you stand up, along with falls and fainting, especially in the first week and after dose increases.

Both labels say to check your blood pressure before starting and regularly during treatment. If anxiety and blood pressure already worry you, our guide to anxiety and high blood pressure explains how they interact.

Which Is Harder to Stop?

Effexor has the tougher reputation, and the evidence backs it up. A 2024 meta-analysis of 79 studies found discontinuation symptoms in 31% of people stopping an antidepressant, compared with 17% stopping placebo. Venlafaxine was among the drugs linked to more frequent symptoms, and venlafaxine or desvenlafaxine to more severe ones.

Half-life is a likely reason. Venlafaxine’s half-life is about 5 hours and its active metabolite’s about 11, so levels fall quickly after a missed or late dose. The Effexor XR label describes tapering by 75 mg at weekly intervals in studies, notes that some people need several months to stop, and lists postmarketing reports of increased blood pressure after stopping or lowering the dose.

Cymbalta isn’t easy to stop either. In pooled duloxetine trials, 44.3% of people who stopped abruptly reported discontinuation symptoms, compared with 22.9% on placebo. Dizziness was the most common, and most people rated their symptoms mild or moderate. The authors recommended reducing the dose over at least 2 weeks. Cymbalta’s smallest capsule is 20 mg, and the label says not to open it, which makes small final steps harder to plan.

If you’re already thinking about stopping, our guides to Effexor withdrawal and how to taper off Cymbalta walk through what a supervised plan looks like.

How Do You and Your Prescriber Choose?

Your other conditions often make the decision. A few patterns tend to come up:

• Chronic nerve pain, fibromyalgia, or musculoskeletal pain alongside depression or anxiety often points toward Cymbalta.
• Social anxiety disorder or panic disorder often points toward Effexor XR, which carries those FDA approvals.
• Existing high blood pressure calls for careful monitoring with either drug, and Effexor’s dose-related effect is part of the conversation.
• Heavy alcohol use or chronic liver disease rules out Cymbalta, according to its label.
• A history of hard antidepressant withdrawal is worth raising early, since both drugs need a slow taper.

How you’ve responded to medications in the past often tells your prescriber more than any comparison chart. Our guide to how long Cymbalta takes to work can help you set expectations once you start.

How Siggy Fits In

“When side effects start, you’re on your own until the next appointment.” With SNRIs, early nausea, blood pressure changes, and missed-dose symptoms are exactly the things that need a fast answer.

Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including depression and anxiety. The free, anonymous intake takes no name, email, or login, so you can describe your mood, pain, blood pressure history, and current medications honestly. It gathers structured information and doesn’t diagnose you on its own. A licensed prescriber reviews it before anything is prescribed, and you get a downloadable summary you can share with your other clinicians.

Siggy isn’t an emergency service. If you’re having thoughts of harming yourself, call 911 or call or text 988. This article is for education and isn’t a substitute for advice from your own prescriber. It reflects sources available as of November 2026.

Start Your Anonymous Intake

Cymbalta and Effexor share a mechanism but part ways on pain evidence, blood pressure, and withdrawal. Cymbalta has stronger, FDA-approved support for nerve pain and fibromyalgia and a smaller average blood pressure effect, while Effexor XR covers more anxiety conditions and asks for extra care with dose, blood pressure, and tapering. If you’re weighing an SNRI for depression or anxiety, start your anonymous intake with Siggy. It’s free, there’s no name or email required, and a licensed prescriber reviews your full picture before anything is prescribed.